// App-Quantinova.ai

TCT-179 : Safety and Efficacy of Everolimus-Eluting Stents Versus Zotarolimus-Eluting Stents for 3-year of Follow-Up in Real-World Practice

Researchers

Presenter

  • Young Jin Youn

Principal Investigators

  • Sung Gyun Ahn

  • Ji Hyun Lee

  • Jun-Won Lee

  • Seung Hwan Lee

  • Junghan Yoon

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Cardiogenic shock

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved